ENDRA Life Sciences Inc.·4

Apr 15, 4:41 PM ET

Basenese Lou 4

4 · ENDRA Life Sciences Inc. · Filed Apr 15, 2020

Insider Transaction Report

Form 4
Period: 2020-04-09
Basenese Lou
Director
Transactions
  • Award

    Stock Option (right to buy)

    2020-04-09+50,00050,000 total
    Exercise: $0.70Exp: 2030-04-09Common Stock (50,000 underlying)
  • Award

    Common Stock

    2020-04-09+41,58741,587 total
Footnotes (4)
  • [F1]Represents restricted stock units granted in lieu of the Reporting Person's cash retainer payable under the Issuer's Non-Employee Director Compensation Policy for the second, third and fourth quarters of 2020. The restricted stock units vest in three equal installments on the last day of each such calendar quarter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Includes unvested restricted stock units.
  • [F3]Represents a stock option award granted on April 9, 2020 pursuant to the Issuer's Non-Employee Director Compensation Policy.
  • [F4]This stock option grant becomes exercisable in three equal annual installments beginning April 9, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION